0000899243-18-007086.txt : 20180312 0000899243-18-007086.hdr.sgml : 20180312 20180312161117 ACCESSION NUMBER: 0000899243-18-007086 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180301 FILED AS OF DATE: 20180312 DATE AS OF CHANGE: 20180312 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: McDonough John CENTRAL INDEX KEY: 0001615937 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 18683496 MAIL ADDRESS: STREET 1: T2 BIOSYSTEMS, INC. STREET 2: 101 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-01 0 0001492674 T2 Biosystems, Inc. TTOO 0001615937 McDonough John 101 HARTWELL AVENUE LEXINGTON MA 02421 1 1 0 0 President and CEO Stock Option (Right to Buy) 5.08 2018-03-01 4 A 0 300000 0.00 A 2028-03-01 Common Stock 300000 300000 D The stock option vests in 48 equal monthly installments commencing March 1, 2018. /s/ John Sprague, Attorney-in-fact 2018-03-12